{ "case_number": "CAC-UDRP-103559", "time_of_filling": "2021-02-04 10:23:40", "domain_names": [ "Novartisusa.info" ], "case_administrator": "Denisa Bilík (CAC) (Case admin)", "complainant": [ "Novartis AG" ], "complainant_representative": "BRANDIT GmbH", "respondent": [ "Viktor lobak" ], "respondent_representative": null, "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nPARTIES’ CONTENTIONS:\r\n\r\nCOMPLAINANT:\r\n\r\n• The disputed domain name is identical or confusingly similar to the protected mark\r\n\r\nAccording to the Complainant, the disputed domain name , registered on 11 January 2021, incorporates entirely the Complainant’s well-known, distinctive trademark NOVARTIS with the country name \"USA\", which could mislead consumers that the disputed domain name is related to the Complainant and its activities. The addition of the gTLD “.info” does not add any distinctiveness to the disputed domain name. See as an example the WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition (\"WIPO Jurisprudential Overview 3.0\"), paragraph 1.11. as well as the International Business Machines Corporation v. Sledge, Inc. \/ Frank Sledge WIPO Case No. D2014-0581, where the Panel stated the following: \r\n\r\n“In addition, it is generally accepted that the addition of the top-level suffix in the domain name (e.g., “.com”) is to be disregarded under the confusing similarity test”. \r\n\r\nThe Complainant argues that the same reasoning should apply in the current case, and the disputed domain name should be considered confusingly similar to the trademark NOVARTIS. \r\n\r\n• Respondent does not have any rights or legitimate interest in the disputed domain name\r\n\r\nThe Complainant states that it has never granted the Respondent any right to use the NOVARTIS trademark within the disputed domain name, nor is the Respondent affiliated to the Complainant in any form.\r\n\r\nThe Complainant has not found that the Respondent is commonly known by the disputed domain name or that it has legitimate interest over the disputed domain name or the major part of it. When entering the terms “Novartisusa” in the Google search engine, the returned results point to the Complainant and its business activities.\r\n\r\nAccording to the Complainant, the Respondent could have easily performed a similar search before registering the disputed domain name and quickly learned that the Complainant owns the NOVARTIS trademarks and that the Complainant has been using its trademarks in the USA where the Respondent resides, and many other countries worldwide. However, the Respondent still chose to register the disputed domain name as such.\r\n\r\nFrom the Complainant’s perspective, the Respondent deliberately chose the gTLD \".info\" combined with its well-known, distinctive trademark NOVARTIS, very likely with the intention to benefit from the Complainant's worldwide renown to confuse internet users as to the source or sponsorship. Also, the disputed domain name did not resolve to any active website. The Respondent, therefore, has not been using the disputed domain name for any bona fide offering of goods or services.\r\n\r\nTherefore, the Complainant contends that the Respondent has no right nor legitimate interest in respect of the disputed domain name.\r\n\r\n• The disputed domain name has been registered and is being used in bad faith\r\n\r\nAccording to the Complainant, the Respondent has registered the disputed domain name and uses it in bad faith. The Complainant states that the registration of the Complainant’s trademarks predates the registration of the disputed domain name, and the Complainant has never authorized the Respondent to register the disputed domain name. \r\n\r\nGiven the Complainant's renown, the Complainant argues that it is inconceivable that the combination of the well-known, distinctive trademark NOVARTIS with the country name \"USA\" as well as the gTLD \".info\" in the disputed domain name is a deliberate and calculated attempt to improperly benefit from the Complainant’s rights and reputation.\r\n\r\nBecause i) the Respondent very likely knew about the Complainant and its trademark; ii) the Complainant’s trademark NOVARTIS is a well-known, distinctive trademark worldwide and in the USA where the Respondent resides; and iii) the Respondent has failed in presenting a credible evidence-backed rationale for registering the disputed domain name, the disputed domain name shall be according to the Complainant deemed as registered in bad faith, which is supported by WIPO Overview 3.0, para. 3.1.1. and para. 3.1.4.\r\n\r\nFinally, the Complainant submits that it has tried to reach the Respondent by a cease-and-desist letter sent on 14 January 2021. The Complainant has not received any response from the Respondent. Since the amicable approach has been unsuccessful, the Complainant chose to file a UDRP complaint.\r\n", "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name .", "no_response_filed": "RESPONDENT:\r\n\r\nNO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.\r\n\r\n", "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).", "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).", "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).", "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.", "decision": "Accepted", "panelists": [ "Mgr. Barbora Donathová, LL.M." ], "date_of_panel_decision": "2021-03-11 00:00:00", "informal_english_translation": "According to the Complainant, Novartis AG is \"one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs\".\r\n\r\nThe Complainant’s products are manufactured and sold in many regions worldwide. The Complainant has especially a strong presence in the United States of America (the “USA”), where the Respondent is located. \r\n\r\nThe Complainant is the trademark owner for \"NOVARTIS\" as a word and figure mark in several classes in numerous countries worldwide. These trademark registrations significantly predate the registration of the disputed domain name. \r\n\r\nThe Complainant has registered several domain names, including the NOVARTIS mark, such as (registered 2 April 1996) and (registered 19 April 2002). The Complainant uses these domain names to promote the NOVARTIS mark with related products and services.\r\n\r\nThe disputed domain name was registered on 11 January 2021.", "decision_domains": { "NOVARTISUSA.INFO": "TRANSFERRED" }, "panelist": null, "panellists_text": null }